Table 3.
IFITM1 and CD10 Qualitative (Positive vs Negative) Expression in Areas of Adenocarcinoma With Myoinvasion and Adenomyosis Involvement
| Characteristic | Value |
|---|---|
| CD10 | |
| Positive (n = 50), No. (%) | |
| Noninvasive | 34 (97.1) |
| Invasive | 16 (84.2) |
| Negative (n = 4), No. (%) | |
| Noninvasive | 1 (2.9) |
| Invasive | 3 (15.8) |
| Sensitivity, % | 97.1 |
| Specificity, % | 15.7 |
| PPV, % | 68.0 |
| NPV, % | 75.0 |
| Accuracy | 0.68 |
| IFITM1 | |
| Positive (n = 25), No. (%) | |
| Noninvasive | 25 (71.4) |
| Invasive | 0 |
| Negative (n = 29), No. (%) | |
| Noninvasive | 10 (28.6) |
| Invasive | 19 (100) |
| Sensitivity, % | 71.4 |
| Specificity, % | 100 |
| PPV, % | 100 |
| NPV, % | 65.5 |
| Accuracy | 0.81 |
IFITM1, interferon-induced transmembrane protein 1; NPV, negative predictive value; PPV, positive predictive value.